4398 J. Am. Chem. Soc., Vol. 123, No. 19, 2001
Bilgic¸er et al.
(Gdn‚HCl, Fisher Scientific, electrophoresis grade), 2-(1H-benzotriazol-
1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU, Quan-
tum Biotechnologies), 4-methylbenzhydrylamine resin (MBHA, Nov-
abiochem), anisole (anhydrous, Aldrich), and trifluoroethanol (99%,
Acros) were used without further purification. N-Boc-R-amino acids
were used as obtained from Novabiochem, Advanced Chemtech or
American Peptide Company. Hydrogen fluoride was purchased from
Matheson Gas.
Preparation of Fluorinated Amino Acids for Peptide Synthesis.
DL-Trifluoroleucine and DL-trifluorovaline were purchased from Oak-
wood Chemicals or prepared by literature procedures.36 The N-acetyl
derivatives of both 5,5,5-trifluoroleucine36c and 4,4,4-trifluorovaline36b
are known. The N-acetyl amino acids were then deacylated by porcine
kidney acylase I, using a modification of a known literature procedure.27a
Details of acetylation and deacylation reactions are given in the
Supporting Information. The hydrochloride salts of the amino acids
with S stereochemistry at CR were t-Boc protected on the amino
terminus by using a mild protection method37 and after purification
were used directly in solid-phase peptide synthesis.
similar Tm values. However, in sedimentation equilibrium experiments,
the residuals were large and non-random for material obtained from
this peak (even after repeated purification), preventing us from assigning
a unique oligomerization state.
Circular Dichroism. CD spectra were obtained on a JASCO J-715
spectropolarimeter fitted with a PTC-423S single position Peltier
temperature controller. Buffer conditions were 10 mM phosphate (pH
7.40), 137 mM NaCl, 2.7 mM KCl unless otherwise noted. The
spectrometer was calibrated with an aqueous solution of recrystallized
d10-(+)-camphorsulfonic acid at 290.5 nm. The concentrations of the
peptide stock solutions were determined by amino acid analysis (average
of 3 runs) or by integration of the tyrosine absorbance on analytical
HPLC relative to standard N-acetyltyrosinamide (ꢀ ) 1490 M-1 cm-1).
Mean residue ellipticities (deg cm2 dmol-1) were calculated by using
the relation:
[θ] ) θobs × MRW/10‚l‚c
(1)
where θobs is the measured signal (ellipticity) in millidegrees, l is the
optical path length of the cell in cm, c is concentration of the peptide
in mg/mL, and MRW is the mean residue molecular weight (molecular
weight of the peptide divided by the number of residues).
Thermal denaturation studies were carried out at the concentrations
indicated by monitoring the change in [θ]222 as a function of temper-
ature. Temperature was increased in steps of 0.5 °C with an intervening
equilibration time of 120 s. Data were collected over 16 s per point.
The Tm was determined from the minima of the first derivative of [θ]222
with T-1, where T is in K. All thermal melts were reversible with g97%
of the starting signal regained upon cooling.
N-(t-Boc)-(2S,4S),(2S,4R)-trifluoroleucine (5). (2S,4S),(2S,4R)-
5,5,5-trifluoroleucine HCl salt (1.00 g, 4.5 mmol), NaHCO3 (1.14 g,
13.5 mmol), and (Boc)2O (1.08 g, 5.0 mmol) were suspended in 22
mL of MeOH and sonicated for 1 h. The reaction mixture was filtered.
Rotary evaporation of the filtrate gave a white solid. Further purification
of this material by C18 reversed phase column chromatography (30%
CH3CN/H2O, 0.25% HOAc eluant) provided pure N-t-Boc-5,5,5-
1
(2S,4S),(2S,4R)-trifluoroleucine in 80% yield (1.05 g). H NMR (300
MHz, D2O) [mixture of two diastereomers] δ 1.13 (d, 3H, J ) 6.8
Hz), 1.42 (s, 9H), 1.58-2.13 (m, 2H), 2.30-2.48 (m, 1H), 3.90-4.02
(m, 1H). GC-MS (CI, CH4): calcd for C11H18F3NO4 285.28, found 286
([M + 1]+).
Gdn‚HCl Denaturation. Denaturation experiments were carried out
assuming a two-state unfolding transition.39
N-(t-Boc)-(2S,3S),(2S,3R)-trifluorovaline (6). (2S,3S),(2S,3R)-Tri-
fluorovaline hydrochloride salt (1.00 g, 4.8 mmol) was t-Boc protected
following the protocol given for trifluoroleucine above to yield the
desired product in 82% yield (1.07 g). 1H NMR (300 MHz, D2O) [23%
(2S,3S); 77% (2S,3R)] δ [1.06 (d, J ) 7.2 Hz), (2S,3R), 1.16 (d, J )
7.1 Hz), (2S,3S)] (3H), 1.41 (s, 9H), 2.90-2.95 (m, 1H), [4.12 (d, J )
5.1 Hz), (2S,3S), 4.43 (d, J ) 2.6 Hz), (2S,3R)] (1H). GC-MS (CI,
CH4): calcd for C10H16F3NO4 271.25, found 272 ([M + 1]+).
Peptide Synthesis. Peptides were prepared by using the N-tert-
butyloxycarbonyl (t-Boc) amino acid derivatives for Merrifield manual
solid-phase synthesis (MBHA resin), using the in situ neutralization/
HBTU protocol typically on a 0.5 mmol scale.29 N-R-Boc-R-S-amino
acids were used with the following side chain protecting groups: Arg-
(Tos), Asp(OBzl), Asn(Xan), Gln(Xan), Cys(Acm), Glu(OBzl), Lys-
(2-Cl-Z), Ser(Bzl), and Tyr(2-Br-Z). Peptide coupling reactions were
carried out with a 4-fold excess (2.0 mmol) of activated amino acid
for at least 15 min. Peptides were cleaved from the resin by using high
HF conditions (90% anhydrous HF/10% anisole at 0 °C for 1.5 h).38
Purification. Peptides were desalted by reversed phase HPLC
[Vydac C4 column with a 30 min linear gradient of 20-40%
acetonitrile/H2O/0.1% TFA at 8.0 mL/min]. Further purification of 2
was carried out by ion exchange chromatography by using reverse
organic conditions [PolyWAX A column from PolyLC, Inc., Columbia,
MD (200 × 9.4 mm, 5 µm, 300 Å)]. Following purification by ion-
exchange chromatography, 2 was again subjected to purification and
desalting by reversed phase HPLC (Vydac C18 column, 22 mm × 250
mm, 300 Å size, 10-15 µm). There were two peaks in the reversed
phase that could be separated (Figure 2). The studies reported in this
paper were all carried out with the peak eluting at 16.65 min [Figure
2B]. The other peak eluted at 15.69 min (under the conditions of Figure
2B), gave similar CD spectra at 5 µM concentration, and also shows
D h 2M
where Kd ) [M]2/[D] (M ) monomer and D ) dimer). Given that the
total peptide concentration, Pt, in terms of monomers is Pt ) 2[D] +
[M], the CD signal Yobs can be described in terms of folded and unfolded
baselines, Yfol and Yunfol, respectively, by the following expression.40
K
x
2 + 8KdPt - K
4Pt
d
Yobs ) (Yunfol - Yfol)
d + Yfol
(2)
Furthermore, Kd can be expressed in terms of the free energy of
unfolding,
Kd ) exp(-∆G°/RT)
(3)
and assuming that the apparent free energy difference between folded
dimer and unfolded monomer states is linearly dependent on the Gdn‚
HCl concentration, ∆G° can be written as:
∆G° ) ∆GH° O - m[Gdn‚HCl]
(4)
2
where ∆G° is the free energy difference in the absence of denatur-
H2O
ant and m is the dependency of the unfolding transition with respect to
the concentration of Gdn‚HCl.41 The data were fit for two parameters,
namely ∆G° and m, by nonlinear least-squares fitting (Kalieda-
H2O
Graph v3.5).
Analytical Ultracentrifugation. Apparent molecular masses were
determined by sedimentation equilibrium on a Beckman XL-A ultra-
centrifuge. Loading peptide concentrations were 5-30 µM in 10 mM
phosphate (pH 7.40), 137 mM NaCl, 2.7 mM KCl. The samples were
centrifuged at 32 000 and 26 000 rpm for 18 h at 10 °C before
absorbance scans were performed. Data obtained at 10 °C were fit
globally to an equation that describes the sedimentation of a homoge-
(36) (a) Rennert, O. M.; Anker, H. S. Biochemistry 1963, 2, 471. (b)
Ojima, I.; Kato, K.; Nakahashi, K. J. Org. Chem. 1989, 54, 4511-22. (c)
Tsushima, T.; Kawada, K.; Ishihara, S.; Uchida, N.; Shiratori, O.; Higaki,
J.; Hirata, M. Tetrahedron 1988, 44, 5375. (d) Weinges, K.; Kromm, E.
Liebigs Ann. Chem. 1985, 90-102.
(37) Einhorn, J.; Einhorn, C.; Luche, J.-L. Synlett 1991, 37-38.
(38) Tam J. P.; Merrifield, R. B. In The Peptides; Udenfriend, S.,
Meienhofer, J., Eds.; Academic Press Inc.: New York, NY, 1987; Vol. 9,
p 185.
(39) (a) Tanford, C. AdV. Protein Chem. 1970, 24, 1. (b) Pace, C. N.
Methods Enzymol. 1986, 131, 266.
(40) Zhu, H.; Celinski, S. A.; Scholtz, J. M.; Hu, J. C. J. Mol. Biol.
2000, 300, 1379-1389.
(41) (a) Becktel, W. J.; Schellman, J. A. Biopolymers 1987, 26, 1859-
1877. (b) Matthews, B. W. Biochemistry 1987, 26, 6885-6888.